# Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition

> **NCT01735370** · PHASE1 · COMPLETED · sponsor: **IPCA Laboratories Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Fasting

## Interventions

- **DRUG:** Etodolac Tablets USP 500mg
- **DRUG:** Etodolac Tablets USP 500 mg

## Key facts

- **NCT ID:** NCT01735370
- **Lead sponsor:** IPCA Laboratories Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735370, "Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01735370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*